Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

Special formulation of inhaled niclosamide may be effective against SARS-CoV-2

• Download PDF Copy

By Dr. Ramya Dwivedi, Ph.D.Sep 28 2020

Healthcare systems worldwide are overwhelmed by the raging COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current number of global infections of SARS-CoV-2 nears 33 million individuals, an effective treatment or vaccine option is crucial and desperately needed.